| Predicate |
Object |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-404
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D215-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D211-96
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-04 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D215-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-404
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D211-96 |
| filingDate |
2019-03-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2021-12-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate |
2021-12-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CN-111868059-B |
| titleOfInvention |
Trifluoromethyl-substituted sulfonamide-selective BCL-2 inhibitors |
| abstract |
It relates to trifluoromethyl-substituted sulfonamide-type selective BCL-2 inhibitors, in particular to compounds of formula (I), stereoisomers or pharmaceutically acceptable salts thereof, and pharmaceutical compositions containing these compounds. It also relates to the use of these compounds and pharmaceutical compositions comprising these compounds in the treatment of diseases associated with the anti-apoptotic protein BCL-2, such as cancer. |
| priorityDate |
2018-03-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |